Machine learning models can predict postoperative hyperopic shift in patients with primary angle-closure glaucoma.

A 12-year study of patients with preperimetric glaucoma finds 35.5% convert to primary open-angle glaucoma, often within 5 years.

An IOL-mounted sustained bimatoprost delivery system demonstrated a reduction in IOP in two clinical trials of patients with glaucoma or ocular hypertension, according to a press release from SpyGlass ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Endoscopic cyclophotocoagulation combined with cataract surgery was better at lowering IOP than cataract surgery alone in ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Paul Badawi, Founder and CEO of Sight Sciences and Leon Herndon, MD, Duke University Eye Center, Durham, NC, commented on the ...

We are proud to continuously support the study of interventional glaucoma treatment, especially in highlighting critical groups of patients that may benefit from active surgical interventions. These ...

Sociodemographic factors, including residence in a socioeconomically distressed or rural area, can make it more likely that patients will present with advanced glaucoma.

First-in-Human(FIH)Trialat36Months:37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose ...

DEAR MISS MANNERS: I work for a midsized company that has a centralized administrative office, in addition to locations where we do field work. I am part of the administration, and work permanently ...

Primary open-angle glaucoma (POAG) is among the leading causes of irreversible blindness. Early detection and treatment are crucial for vision preservation, and research to identify genes associated ...